| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/14/2002 | US6387368 Hybrid adenovirus-AAV virus and methods of use thereof |
| 05/14/2002 | US6387366 Reducing the biological activity of tissue factor, tf; bone marrow cells; antisense oligonucleotide or ribozyme which inhibits expression of tissue factor (tf) or an antibody that binds to and inhibits tf |
| 05/14/2002 | US6387031 Array centrifuge |
| 05/14/2002 | CA2249666C Macrophage stimulating protein for the treatment of gastrointestinal disorders |
| 05/14/2002 | CA2249180C Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides |
| 05/14/2002 | CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 05/14/2002 | CA2144601C Recombinant type ii collagenase from clostridium histolyticum and its use for isolating cells and groups of cells |
| 05/14/2002 | CA2130800C Plant genes encoding flavonoid-3',5'-hydroxylase |
| 05/14/2002 | CA2089742C Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 05/14/2002 | CA2086323C Functionally active selectin-derived peptides and ligand for gmp-140 |
| 05/14/2002 | CA2065409C Anticoagulant polypeptides |
| 05/14/2002 | CA2023899C Anti-sense oligonucleotide sequence, anti-rna messenger of tnf alpha, process for its preparation, use as medicament and pharmaceutical composition |
| 05/10/2002 | WO2002037398A2 Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
| 05/10/2002 | WO2002037077A2 Screening methods based on transcriptional regulation analysis system using transformed cell lines |
| 05/10/2002 | WO2002036832A2 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 05/10/2002 | WO2002036831A2 Canola event pv-bngt04(rt73) and compositions and methods for detection thereof |
| 05/10/2002 | WO2002036829A2 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/10/2002 | WO2002036828A2 COMPOSITIONS AND SYSTEMS FOR IDENTIFYING AND COMPARING EXPRESSED GENES (mRNAs) IN EUKARYOTIC ORGANISMS |
| 05/10/2002 | WO2002036824A1 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1 |
| 05/10/2002 | WO2002036823A1 Method of searching for gene encoding nuclear transport protein |
| 05/10/2002 | WO2002036821A2 Method for the amplification and optional characterisation of nucleic acids |
| 05/10/2002 | WO2002036820A2 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat |
| 05/10/2002 | WO2002036817A2 Method and kit to determine lp-pla2 polymorphic variants associated with susceptibility to atherosclerosis |
| 05/10/2002 | WO2002036811A1 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 05/10/2002 | WO2002036810A2 Antisense modulation of talin expression |
| 05/10/2002 | WO2002036809A2 Antisense modulation of sr-cyp expression |
| 05/10/2002 | WO2002036807A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | WO2002036800A1 Process for producing nucleoside compound |
| 05/10/2002 | WO2002036797A2 Process for the fermentative preparation of l-amino acids using strains of the enterobacteriaceae family |
| 05/10/2002 | WO2002036793A2 Secreted protein associated with depression; composition and methods of use thereof |
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036791A2 Nucleus export reporter system |
| 05/10/2002 | WO2002036790A2 Influenza virus vector for infection of dendritic cells |
| 05/10/2002 | WO2002036789A2 Methods of modifying eukaryotic cells |
| 05/10/2002 | WO2002036788A2 Nucleic acids and polypeptides specifically expressed in cells of the transfer zone of a plant seed and uses thereof |
| 05/10/2002 | WO2002036787A2 Herbicide-tolerant plants through bypassing metabolic pathway |
| 05/10/2002 | WO2002036786A2 Method of selecting plant promoters to control transgene expression |
| 05/10/2002 | WO2002036785A1 Protein complexes and process for producing the same |
| 05/10/2002 | WO2002036784A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 05/10/2002 | WO2002036783A2 Regulation of human histone deacetylase |
| 05/10/2002 | WO2002036782A2 Novel glyphosate n-acetyltransferase (gat) genes |
| 05/10/2002 | WO2002036781A2 Regulation of human glutathione-s-transferase |
| 05/10/2002 | WO2002036780A2 Stearoyl-coa desaturase gene promoter |
| 05/10/2002 | WO2002036779A1 Novel glucose dehydrogenase and process for producing the dehydrogenase |
| 05/10/2002 | WO2002036778A1 Process for producing enzyme protein converting methane into methanol |
| 05/10/2002 | WO2002036777A1 aopB GENE, PROTEIN, HOMOLOGS, FRAGMENTS AND VARIANTS THEREOF, AND THEIR USE FOR CELL SURFACE DISPLAY |
| 05/10/2002 | WO2002036776A1 Improvement of plant flower type targeting mads box gene |
| 05/10/2002 | WO2002036775A1 A novel plant agglutinin gene |
| 05/10/2002 | WO2002036774A2 Derivatives of the human macrophage-migration inhibition factor (mif) and use thereof in pharmaceutical preparations in screening methods or the identification of analogues, agonists and antagonists |
| 05/10/2002 | WO2002036773A2 Nod2 nucleic acids and proteins |
| 05/10/2002 | WO2002036772A1 Novel disease-associated gene and use thereof |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036770A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | WO2002036769A2 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof |
| 05/10/2002 | WO2002036768A1 Cell division autoantigen (cda) polypeptides, gene sequences and uses thereof |
| 05/10/2002 | WO2002036767A2 Therapeutic oligonucleotides of reduced toxicity |
| 05/10/2002 | WO2002036766A2 Protein-protein complexes and methods of using same |
| 05/10/2002 | WO2002036765A1 Novel protein and dna thereof |
| 05/10/2002 | WO2002036764A1 Method of constructing averaged dna libraries and averaged dna arrays |
| 05/10/2002 | WO2002036762A1 Process for producing peptide |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036760A2 Methods for expressing endogenous genes by restriction enzyme mediated integration |
| 05/10/2002 | WO2002036759A2 Polynucleotides encoding human meltrin beta (adam19) metalloendopeptidases |
| 05/10/2002 | WO2002036756A2 Lactobacillus strain, and plasmid hosted by same |
| 05/10/2002 | WO2002036755A2 Regulation of human inositolpolyphosphate 5-phosphatase |
| 05/10/2002 | WO2002036754A2 Nucleotide and polypeptide sequence of human lysosomal acid lipase |
| 05/10/2002 | WO2002036753A2 Human triacylglycerol lipase |
| 05/10/2002 | WO2002036752A2 Method of producing non-bovine chymosin and use thereof |
| 05/10/2002 | WO2002036747A2 Peripheral nerve type sodium channels |
| 05/10/2002 | WO2002036743A2 Antisense modulation of calreticulin expression |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036740A2 Apoptosis-inducing ribozymes |
| 05/10/2002 | WO2002036738A2 Affinity maturation by competitive selection |
| 05/10/2002 | WO2002036736A2 Alpha-tocopherol transfer protein knockout animals |
| 05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | WO2002036633A2 Human 7tm proteins and polynucleotides encoding the same |
| 05/10/2002 | WO2002036632A2 Single nucleotide polymorphisms in nucleic acids encoding human olfactory receptor-like polypeptides |
| 05/10/2002 | WO2002036631A1 Method of screening antiplatelet |
| 05/10/2002 | WO2002036630A2 Renin and/or proprenin receptor protein, nucleic acid coding for same and uses thereof |
| 05/10/2002 | WO2002036629A2 Regulation of human serotonin receptor precursor |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036623A2 Ghep, a gene highly expressed in normal and neoplastic prostate, and uses therefor |
| 05/10/2002 | WO2002036622A2 GαqPROETIN VARIANTS AND THEIR USE IN THE ANALYSIS AND DISCOVERY OF AGONISTS AND ANTAGONISTS OF CHEMOSENSORY RECEPTORS |
| 05/10/2002 | WO2002036621A1 Medical and diagnostic use of a specific co-activator for human nuclear receptors |
| 05/10/2002 | WO2002036620A2 Ets-transcription factor related compound specific promoter and transactivators thereof |
| 05/10/2002 | WO2002036619A1 A new polypeptide-human glycoprotein 42 and the polynucleotide encoding it |
| 05/10/2002 | WO2002036617A2 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 05/10/2002 | WO2002036616A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036613A2 Regulation of human patched-like protein |
| 05/10/2002 | WO2002036611A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | WO2002036167A1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 05/10/2002 | WO2002036150A1 Gene-digesting gene and enzyme having vaccine-like effect |
| 05/10/2002 | WO2002036149A2 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof |
| 05/10/2002 | WO2002036131A1 In vivo stimulation of angiogenic activity |
| 05/10/2002 | WO2002036076A2 Cell lines expressing a mch receptor |
| 05/10/2002 | WO2002036070A2 Novel fish chemokine and methods for use |
| 05/10/2002 | WO2002035923A1 Hypertension |
| 05/10/2002 | WO2002022798A3 Modulation of homologous recombination with single stranded dna binding proteins |